These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 3587709
41. [Physiopathology and treatment of ascites in the cirrhotic patient]. Rodés J, Arroyo V. Rev Med Brux; 1987 Apr; 8(4):204-8. PubMed ID: 3589268 [No Abstract] [Full Text] [Related]
42. [Ascites in pregnancy in liver cirrhosis]. Huchzermeyer H. Z Geburtshilfe Gynakol; 1970 Apr; 172(2):142-8. PubMed ID: 5516067 [No Abstract] [Full Text] [Related]
46. Antidiuretic hormone and the pathogenesis of water retention in cirrhosis with ascites. Arroyo V, Clària J, Saló J, Jiménez W. Semin Liver Dis; 1994 Feb; 14(1):44-58. PubMed ID: 8016662 [No Abstract] [Full Text] [Related]
48. Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? Gentilini P, Laffi G, La Villa G, Romanelli RG, Blendis LM. J Hepatol; 1999 Dec; 31(6):1088-97. PubMed ID: 10604585 [No Abstract] [Full Text] [Related]
49. Mechanisms of disturbed renal water excretion in cirrhosis. Schrier RW. Gastroenterology; 1983 Apr; 84(4):870-2. PubMed ID: 6825997 [No Abstract] [Full Text] [Related]
50. Pathogenesis of water and sodium retention in cirrhosis. Martin PY, Schrier RW. Kidney Int Suppl; 1997 Jun; 59():S43-9. PubMed ID: 9185104 [Abstract] [Full Text] [Related]
51. Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management. Arroyo V, Colmenero J. J Hepatol; 2003 Jun; 38 Suppl 1():S69-89. PubMed ID: 12591187 [No Abstract] [Full Text] [Related]
52. [New aspects of the physiopathology and treatment of the hepatorenal syndrome]. Pavão dos Santos OF, Schor N, Higa EM, Sigulem D, Ramos OL. AMB Rev Assoc Med Bras; 1984 Jun; 30(1-2):20-5. PubMed ID: 6377404 [No Abstract] [Full Text] [Related]
53. [Influence of circulatory dysfunction on the treatment of ascites and hepatorenal syndrome: vasoconstrictor and diuretic drug treatment]. Torre A, Terra C, Guevara M, Ginès P. Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():8-14. PubMed ID: 15195529 [No Abstract] [Full Text] [Related]
54. Prognostic markers in patients with ascites and hepatorenal syndrome. Nazal L, Cárdenas A. Dis Markers; 2011 Feb; 31(3):139-46. PubMed ID: 22045399 [No Abstract] [Full Text] [Related]
55. [Abdominal pain with ascites. Hepatorenal syndrome]. Schwietert M. Praxis (Bern 1994); 1999 May 12; 88(20):920-2. PubMed ID: 10409894 [No Abstract] [Full Text] [Related]
56. [Concentration of antidiuretic hormone in the blood of patients with cirrhosis of the liver with ascites]. Berezov VM. Ter Arkh; 1967 Mar 12; 39(3):20-3. PubMed ID: 5616771 [No Abstract] [Full Text] [Related]
57. Ascites formation in cirrhosis and its management. Sherlock S. Scand J Gastroenterol Suppl; 1970 Mar 12; 7():9-15. PubMed ID: 4917041 [No Abstract] [Full Text] [Related]
58. [Current concepts on the physiopathology of cirrhotic ascites]. Secretan P. Praxis; 1966 Sep 08; 55(36):1010-2. PubMed ID: 5953180 [No Abstract] [Full Text] [Related]
60. [Refractory hepatic cirrosis and the ineffectiveness of diuretics in ascites and edema]. Inoue J, Mori Y, Kawamura T. Naika; 1969 Nov 08; 24(5):834-9. PubMed ID: 4902224 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]